During the past decade, Emerson Clinical Research Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emerson Clinical Research Institute" #1 sponsor was "Aerie Pharmaceuticals" with 2 trials, followed by "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Sucampo Pharma Americas, LLC" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emerson Clinical Research Institute" #1 collaborator was "Sucampo AG" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Emerson Clinical Research Institute" are "Constipation - Functional" (2 trials), "Diabetic Macular Edema" (2 trials), "Bacterial Conjunctivitis" (1 trials), "Diabetic Retinopathy" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Emerson Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Emerson Clinical Research Institute" are "Drug" (11 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (3 trials), "Faricimab" (2 trials), "Lubiprostone" (2 trials), "Placebo" (2 trials) and "APL-2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emerson Clinical Research Institute" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Emerson Clinical Research Institute". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Emerson Clinical Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emerson Clinical Research Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".